USA, New York 
Dr. Fred R. Hirsch is a medical oncologist and translational researcher at the Icahn School of Medicine at Mount Sinai and Tisch Cancer Institute, internationally recognized for his contributions to lung cancer research, biomarker development, and precision oncology.
Current Role
- Ning Zhao Chair & Professor of Medicine (Hematology/Oncology) and Pathology, Icahn School of Medicine at Mount Sinai
- Executive Director, Center for Thoracic Oncology, Tisch Cancer Institute
- Co-Director, Center of Excellence for Thoracic Oncology
- Associate Director of Biomarker Discovery
Education
- MD, University of Copenhagen
- PhD, University of Copenhagen
- BA, Copenhagen Business School
Clinical & Research Focus
- Lung cancer
- Translational oncology
- Biomarker development and validation
- Targeted therapies and precision medicine
- Early detection strategies
Academic Profile
- Author of 400–500+ peer-reviewed publications
- Principal investigator in multiple international clinical trials
- Leader in biomarker-driven lung cancer research
Leadership & Global Impact
- Former CEO, International Association for the Study of Lung Cancer
- Leadership roles in: Lung cancer translational research groups
- International oncology collaborations
- Contributor to global advances in personalized lung cancer therapy